Morgan Stanley upgrades Gilead on HIV treatment growth
Go back to Morgan Stanley upgrades Gilead on HIV treatment growth| Gilead Sciences (NASDAQ: GILD) | Delayed: 146.12 +2.68 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.44 | 52 Week High | $108.63 | |||
| Open | $144.52 | 52 Week Low | $71.39 | |||
| Day High | $147.91 | P/E | 80.73 | |||
| Day Low | $143.50 | EPS | $1.81 | |||
| Volume | 5,384,399 | |||||
| Morgan Stanley (NYSE: MS) | Delayed: 214.20 +6.75 (3.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $207.45 | 52 Week High | $39.88 | |||
| Open | $210.08 | 52 Week Low | $21.16 | |||
| Day High | $214.57 | P/E | 149.79 | |||
| Day Low | $209.13 | EPS | $1.43 | |||
| Volume | 4,572,376 | |||||
